and Its Virulence Factors HO and Pneumolysin Are Potent Mediators of the Acute Chest Syndrome in Sickle Cell Disease
Overview
Authors
Affiliations
Sickle cell disease (SCD) is one of the most common autosomal recessive disorders in the world. Due to functional asplenia, a dysfunctional antibody response, antibiotic drug resistance and poor response to immunization, SCD patients have impaired immunity. A leading cause of hospitalization and death in SCD patients is the acute chest syndrome (ACS). This complication is especially manifested upon infection of SCD patients with ()-a facultative anaerobic Gram-positive bacterium that causes lower respiratory tract infections. has developed increased rates of antibiotics resistance and is particularly virulent in SCD patients. The primary defense against is the generation of reactive oxygen species (ROS) during the oxidative burst of neutrophils and macrophages. Paradoxically, itself produces high levels of the ROS hydrogen peroxide (HO) as a virulence strategy. Apart from HO, also secretes another virulence factor, i.e., the pore-forming exotoxin pneumolysin (PLY), a potent mediator of lung injury in patients with pneumonia in general and particularly in those with SCD. PLY is released early on in infection either by autolysis or bacterial lysis following the treatment with antibiotics and has a broad range of biological activities. This review will discuss recent findings on the role of pneumococci in ACS pathogenesis and on strategies to counteract the devastating effects of its virulence factors on the lungs in SCD patients.
Infections in sickle cell disease.
Scourfield L, Nardo-Marino A, Williams T, Rees D Haematologica. 2024; 110(3):546-561.
PMID: 39568431 PMC: 11873697. DOI: 10.3324/haematol.2024.285066.
Unraveling the full impact of SPD_0739: a key effector in iron homeostasis.
Womack E, Antone M, Eichenbaum Z Microbiol Spectr. 2024; :e0133124.
PMID: 39470285 PMC: 11620282. DOI: 10.1128/spectrum.01331-24.
Endogenously produced HO is intimately involved in iron metabolism in .
Womack E, Alibayov B, Vidal J, Eichenbaum Z Microbiol Spectr. 2023; 12(1):e0329723.
PMID: 38038454 PMC: 10783112. DOI: 10.1128/spectrum.03297-23.
Zhang M, Zhang X, Pei J, Guo B, Zhang G, Li M Heliyon. 2023; 9(3):e14029.
PMID: 36911881 PMC: 9977108. DOI: 10.1016/j.heliyon.2023.e14029.
Gu K, Ding L, Wang Z, Sun Y, Sun X, Yang W J Cell Mol Med. 2023; 27(4):563-575.
PMID: 36747468 PMC: 9930429. DOI: 10.1111/jcmm.17684.